As many as 100,000 patients had a cancer that was missed, or had their diagnoses or treatments delayed during the lockdowns of 2020 and 2021. That’s the shocking finding of a recent study by the Institute of Cancer Policy at King’s College London.

The experts conclude that some patients will already have died, many still haven’t been diagnosed and others will already have a more advanced cancer as a result of the delays.